Amyloid-Binding Aptamer Conjugated Curcumin–PLGA Nanoparticle for Potential Use in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Amyloid-Binding Aptamer Conjugated Curcumin–PLGA Nanoparticle for Potential Use in Alzheimer’s Disease

Published:2012-02-29 Issue:2 Volume:2 Page:83-93
ISSN:2191-1630
Container-title:BioNanoScience
language:en
Short-container-title:BioNanoSci.

Author:

Mathew Anila,Aravind Athulya,Brahatheeswaran D.,Fukuda Takahiro,Nagaoka Yutaka,Hasumura Takashi,Iwai Seiki,Morimoto Hisao,Yoshida Yasuhiko,Maekawa Toru,Venugopal K.,Kumar D. Sakthi

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Bioengineering

Link

http://link.springer.com/content/pdf/10.1007/s12668-012-0040-y.pdf

Reference36 articles.

1. Hardy, J., Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297, 353–356. doi: 10.1126/science.1072994 .

2. Mathew, A., Yoshida, Y., Maekawa, T., Sakthi Kumar, D. (2011). Alzheimer's disease: Cholesterol a menace? Brain Research Bulletin, 86, 1–12. doi: 10.1016/j.brainresbull.2011.06.006 .

3. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., Bateman, R. J. (2010). Decreased clearance of CNS β-amyloid in Alzheimer’s disease. Science, 330, 1774. doi: 10.1126/science.1197623 .

4. Ghiso, J., & Frangione, B. (2002). Amyloidosis and Alzheimer’s disease. Advanced Drug Delivery Reviews, 54, 1539–1551. doi: 10.1016/S0169-409X(02)00149-7 .

5. Karran, E., Mercken, M., Strooper, B. D. (2011). The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nature Review Drug Discovery, 10, 698–712. doi: 10.1038/nrd3505 .

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review;Ageing Research Reviews;2024-08

2. Nano formulation approaches for curcumin delivery- a review;Journal of Drug Delivery Science and Technology;2023-04

3. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease;Antioxidants & Redox Signaling;2023-02-23

4. Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer’s Disease Management;Molecules;2022-12-19

5. Heparin‐Derived Theranostic Nanoprobes Overcome the Blood–Brain Barrier and Target Glioma in Murine Model;Advanced Therapeutics;2022-03-23